aap Implantate AG (LON:0N5A)
1.480
-0.140 (-8.64%)
At close: Oct 31, 2025
aap Implantate AG Revenue
aap Implantate AG had revenue of 6.34M EUR in the half year ending June 30, 2025, with 7.04% growth. This brings the company's revenue in the last twelve months to 12.16M, down -0.44% year-over-year. In the year 2024, aap Implantate AG had annual revenue of 12.29M with 5.37% growth.
Revenue (ttm)
12.16M EUR
Revenue Growth
-0.44%
P/S Ratio
1.70
Revenue / Employee
130.76K EUR
Employees
93
Market Cap
17.71M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.29M | 627.00K | 5.37% |
| Dec 31, 2023 | 11.67M | 9.00K | 0.08% |
| Dec 31, 2022 | 11.66M | -643.00K | -5.23% |
| Dec 31, 2021 | 12.30M | 2.90M | 30.78% |
| Dec 31, 2020 | 9.41M | -3.58M | -27.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |